Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells

Blood

Volumn 110, Issue 7, 2007, Pages 2736-2743

  Hendrickson, Jeanne E ^a   Chadwick, Traci E ^a   Roback, John D ^a   Hillyer, Christopher D ^a   Zimring, James C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ERYTHROCYTE ANTIGEN; POLYINOSINIC POLYCYTIDYLIC ACID;

ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ERYTHROCYTE TRANSFUSION; HUMORAL IMMUNITY; IN VIVO STUDY; INFLAMMATION; LIVER; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLENECTOMY;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; DENDRITIC CELLS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; IMMUNIZATION; INFLAMMATION; LIVER; LYMPH NODES; MACROPHAGES; MICE; POLY I-C; SPLEEN;

EID: 34948877596     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-083105     Document Type: Article

References (47)

1. Blumberg N, Peck K, Ross K, Avila E. Immune response to chronic red blood cell transfusion. Vox Sang. 1983;44:212-217.
2. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion. 1990;30:532-535.
3. Heddle NM, Soutar RL, O'Hoski PL, et al. A prospective study to determine the frequency and clinical significance of alloimmunization posttransfusion. Br J Haematol. 1995;91:1000-1005.
4. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med. 1995;119:42-45.
5. Redman M, Regan F, Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang. 1996;71:216-220.
6. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39:763-771.
7. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37-43.
8. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion. 1997;37:357-361.
9. Moreira G Jr, Bordin JO, Kuroda A, Kerbauy J. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol. 1996;52:197-200.
10. Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res. 2005;38:675-682.
11. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease. Blood. 1990;76:1431-1437.
12. Reviron D, Dettori I, Ferrera V, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion. 2005;45:956-959.
13. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion. 2006;46:1328-1333.
14. Brantley SG, Ramsey G. Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion. 1988;28:463-466.
15. Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion. 1995;35:931-935.
16. Domen RE, Ramirez G. Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis. Nephron. 1988;48:284-285.
17. Shukla JS, Chaudhary RK. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis. Indian J Pathol Microbiol. 1999;42:299-302.
18. Stiegler G, Sperr W, Lorber C, Fabrizii V, Hocker P, Panzer S. Red cell antibodies in frequently transfused patients with myelodysplastic syndrome. Ann Hematol. 2001;80:330-333.
19. Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang. 1990;58:50-55.
20. Seyfried H, Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol. 1990;22:21-25.
21. Endres RO, Grey HM. Antigen recognition by T cells, II: intravenous administration of native or denatured ovalbumin results in tolerance to both forms of the antigen. J Immunol. 1980;125:1521-1525.
22. Weigle WO. Immunological unresponsiveness. Adv Immunol. 1973;16:61-122.
23. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.
24. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol. 2001;13:114-119.
25. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732-738.
26. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46:1526-1536.
27. Ho WY, Cooke MP, Goodnow CC, Davis MM. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med. 1994;179:1539-1549.
28. Lepay DA, Nathan CF, Steinman RM, Murray HW, Cohn ZA. Murine Kupffer cells: mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med. 1985;161:1079-1096.
29. ten Hagen TL, van Vianen W, Bakker-Woudenberg IA. Isolation and characterization of murine Kupffer cells and splenic macrophages. J Immunol Methods. 1996;193:81-91.
30. Zimring JC, Hair GA, Chadwick TE, et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood. 2005;106:1105-1112.
31. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med. 1994;180:631-640.
32. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 1995;2:555-559.
33. Akiba H, Oshima H, Takeda K, et al. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol. 1999;162:7058-7066.
34. Futagawa T, Akiba H, Kodama T, et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol. 2002;14:275-286.
35. Shimozato O, Takeda K, Yagita H, Okumura K. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem Biophys Res Commun. 1999;256:519-526.
36. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol. 1998;16:111-135.
37. Parish CR. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol. 1999;77:499-508.
38. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Ann Rev Immunol. 2005;23:975-1028.
39. Bowen DG, McCaughan GW, Bertolino P. Intrahepatic immunity: a tale of two sites? Trends Immunol. 2005;26:512-517.
40. Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol. 2002;169:2407-2413.
41. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol. 1998;18:389-418.
42. Sivori S, Falco M, Della Chiesa M, et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A. 2004;101:10116-10121.
43. Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol. 2004;172:6065-6073.
44. Salem ML, El-Naggar SA, Kadima A, Gillanders WE, Cole DJ. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine. 2006;24:5119-5132.
45. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 1996;219:339-349.
46. Yu, J, Heck, S, and K. Yazdanbakhsh. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol. Prepublished on May 9, 2007, as DOI 10.1002/ajh. 20959.
47. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369-3373.